Many options are available to treat psoriatic arthritis (PsA), ranging from over-the-counter medicines to highly specialized therapies. Regardless of which is chosen, the overall goal is clear: ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
Psoriatic arthritis is a type of arthritis that develops in some people who have psoriasis, which is a chronic autoimmune disease of the skin. Psoriatic arthritis can be mild or severe. It can also be ...
Please provide your email address to receive an email when new articles are posted on . Selarsdi is approved for the treatment of plaque psoriasis, psoriatic arthritis in adults, patients aged 6 years ...
Arthritis mutilans (AM): This is the most severe and destructive type of PsA, and it primarily affects the joints of the fingers, hands, wrists, and feet. This type may shorten and fuse joints, ...
Real-world registry data from Germany show apremilast improves psoriasis severity and quality of life, with a safety profile consistent with clinical trials.
GRAPPA published treatment recommendations for PsA in 2009 based on evidence from systematic reviews and consensus of 70 rheumatologists and dermatologists with subspecialty expertise in management of ...
With three new indications, BIMZELX® (bimekizumab-bkzx) is the first and only IL-17A and IL-17F inhibitor approved in the U.S. for the treatment of four chronic immune-mediated inflammatory diseases ...
Over time, arthritis mutilans leads to the destruction of the affected bones in your hands, particularly in your fingers. It can also affect your feet. People with arthritis mutilans may eventually ...
Moderate to severe psoriatic arthritis (PsA) correlates with worse mental health and higher financial burden, impacting quality of life and health care utilization. Black participants reported higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results